Parkinson’s Progressive Marker Initiative PPMI - (still enrolling)
This study will collect clinical information, samples of blood, DNA, urine, cerebral spinal fluid, and brain images from subjects with PD and from subjects without PD. . This information will be used to help develop biomarkers for PD. Biomarkers are measures that tell something about PD. This study is looking at biomarkers in PD because they may help to understand how the disease changes over time. Having good biomarkers for PD may also be useful in developing new treatments and may help to improve clinical care in the future. In this study we will test biomarkers that may be related to the way PD changes over time.
To qualify: Age 18 and above with or without PD.